Biotech

All Articles

Otsuka pays $800M for Jnana and its clinical-stage PKU drug

.Otsuka Pharmaceutical has picked up Boston-based Jnana Therapies for $800 million so the Eastern bi...

FibroGen gives up 75% people team as property flunks 2 even more tests

.FibroGen is radically restructuring its service, giving up 75% of its U.S. personnel and ceasing as...

Tracon winds down full weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has chosen to unwind functions weeks after an injectable immune system check...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on neglected epilepsy medication, promotes FDA run

.Our experts already recognize that Takeda is actually expecting to find a road to the FDA for epile...

VBI Injections apply for personal bankruptcy, finds asset purchase

.Immunology biotech VBI Injections is diverting precariously near the defining moment, along with pr...

Celldex anti-cKIT antibody decrease colonies in yet another phase 2 research

.It's challenging to muscle in on a room as very competitive as immunology, however Celldex Therapeu...

Boehringer provides to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Rehabs and a preclinical imm...

Ventyx's last resort for inflammatory med ends in Crohn's failing

.Ventyx Biosciences' Crohn's disease medication did not help people accomplish remission in a phase ...

Cognition's stage 2 beam records stain Alzheimer's prospect

.Knowledge Therapeutics' period 2 sparkle test has actually taken a number of the gloss off the Alzh...